Detalles de la búsqueda
1.
Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study.
Jpn J Clin Oncol
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38884136
2.
A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy.
Jpn J Clin Oncol
; 53(10): 957-965, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408443
3.
Improved survival of poor-risk non-seminomatous germ cell tumor patients: real-world data from a single institute in Japan.
Jpn J Clin Oncol
; 53(1): 74-79, 2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36151048
4.
[A Case of Germ Cell Tumor in which Necrotic Tissue Revealed hCG-Positive in Surgical Specimen of Post-Chemotherapy Retroperitoneal Lymph Node Dissection].
Hinyokika Kiyo
; 69(6): 157-162, 2023 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-37460279
5.
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.
Int J Urol
; 29(5): 398-405, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080069
6.
Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries.
Cancer Sci
; 112(6): 2071-2080, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33738901
7.
Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old.
Cancer Sci
; 112(8): 3074-3082, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014592
8.
Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Int J Urol
; 28(5): 584-591, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33629386
9.
Dynamics of conditional survival and risk factors in androgen deprivation therapy for prostate cancer using a multi-institutional Japan-wide database.
Int J Urol
; 28(9): 927-935, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028097
10.
[Current Clinical Practice Pattern for Castration-Resistant Prostate Cancer(CRPC)in Japan].
Gan To Kagaku Ryoho
; 48(11): 1359-1363, 2021 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-34795127
11.
Primary Androgen-Depletion Therapy Prevails Not Only for Metastatic but Also for Nonmetastatic Hormone-Naïve Prostate Cancer in Japan-Recent Trends and Efficacy.
Gan To Kagaku Ryoho
; 48(7): 911-919, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34267028
12.
A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.
Int J Clin Oncol
; 25(2): 354-361, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595343
13.
Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database.
Int J Urol
; 27(4): 313-318, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037622
14.
The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study.
BMC Urol
; 19(1): 137, 2019 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881875
15.
Bacillus Calmette-Guérin strain differences as the basis for immunotherapies against bladder cancer.
Int J Urol
; 25(5): 405-413, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29506322
16.
Prostate cancer trends in Asia.
World J Urol
; 35(6): 859-865, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27644231
17.
Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy.
World J Urol
; 34(2): 261-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26047654
18.
Long-term survival of extremely advanced prostate cancer patients diagnosed with prostate-specific antigen over 500 ng/ml.
Jpn J Clin Oncol
; 44(12): 1227-32, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25240024
19.
Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.
Jpn J Clin Oncol
; 44(10): 969-81, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25098707
20.
Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy.
Int J Urol
; 21(6): 578-83, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24405474